Alnylam Pharmaceuticals
ALNY
#585
Rank
C$47.02 B
Marketcap
$366.32
Share price
1.81%
Change (1 day)
46.29%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of June 2024 : -C$4.17 M

According to Alnylam Pharmaceuticals 's latest financial reports the company has -C$4.17 M in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-C$0.3 B36.31%
2022-12-31$-C$0.22 B-128.84%
2021-12-31$C$0.74 B-42.56%
2020-12-31$C$1.29 B-30.51%
2019-12-31$C$1.86 B5.01%
2018-12-31$C$1.77 B-20.03%
2017-12-31$C$2.22 B79.59%
2016-12-31$C$1.23 B-29.59%
2015-12-31$C$1.75 B61.73%
2014-12-31$C$1.08 B277.56%
2013-12-31$C$0.28 B115.27%
2012-12-31$C$0.13 B11.31%
2011-12-31$C$0.12 B-24.22%
2010-12-31$C$0.15 B-15.52%
2009-12-31$C$0.18 B-24.09%
2008-12-31$C$0.24 B26.48%
2007-12-31$C$0.19 B-16.63%
2006-12-31$C$0.23 B225.65%
2005-12-31$C$71.92 M42.86%
2004-12-31$C$50.34 M-243.82%
2003-12-31$-C$35.01 M377.1%
2002-12-31$-C$7.34 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$0.45 B-11,152.30%๐Ÿ‡บ๐Ÿ‡ธ USA
C$38.25 B-919,754.39%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.46 B-35,218.03%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.89 B-45,594.62%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.14 B-3,607.92%๐Ÿ‡บ๐Ÿ‡ธ USA
C$56.83 B-1,366,321.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$106.13 B-2,551,505.28%๐Ÿ‡ซ๐Ÿ‡ท France
C$8.90 B-214,087.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel